by Co-Diagnostics | Nov 13, 2019 | News Release
Revenue includes sales of infectious disease, mosquito abatement products and AgBio primer design services Salt Lake City, Utah – November 13, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the...
by Co-Diagnostics | Nov 8, 2019 | Market Update
Following recent Company news of expansion into Africa with the sale and installation to one of the largest private molecular diagnostics laboratories in Ghana, Co-Diagnostics, Inc. (Nasdaq: CODX), today issued a malaria in Africa fact sheet to accompany that release....
